Health
Medical
US

NeoGenomics

$23.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.64 (-2.68%) Today
-$0.01 (-0.04%) As of 6:23 PM EDT after-hours

Why Robinhood?

You can buy or sell NeoGenomics and other stocks, options, ETFs, and crypto commission-free!

About NEO

NeoGenomics, Inc. provides cancer diagnostics and pharma services. It operates through a network of cancer focused testing laboratories to provide genetic and molecular testing services. Read More It offers various testing services, including Cytogenetics, Fluorescence In-Situ Hybridization, Flow Cytometry, Immunohistochemistry, Molecular testing and Pathology consultation. The company operates through two segments: Clinical Services Segment provides various clinical testing services to community-based pathology practices, hospital pathology labs and academic centers with reimbursement from various payers including client direct billing, commercial insurance, Medicare and other government payers, and patients. Pharma Services segment: provides comprehensive testing services in supports pharmaceutical clients' oncology programs from discovery to commercialization. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Employees
1,500
Headquarters
Fort Myers, Florida
Founded
1998
Market Cap
2.27B
Price-Earnings Ratio
361.36
Dividend Yield
0.00
Average Volume
652.70K
High Today
$24.17
Low Today
$23.08
Open Price
$23.88
Volume
583.43K
52 Week High
$24.84
52 Week Low
$11.05

Collections

Health
Medical
US
North America

NEO Earnings

$0.02
$0.04
$0.05
$0.07
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Jul 30, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.